Alector, Inc.

Contributing Author

Recent Articles by Alector, Inc.

Oct-21	Alector Announces Topline Results from Latozinemab Phase 3 Trial in Individuals with Frontotemporal Dementia Due to a GRN Mutation and Provides Business Update ALEC GlobeNewswire
Sep-16	Alector to Host Virtual Research and Development Event Highlighting PGRN Franchise and Brain Carrier Programs ALEC GlobeNewswire
Aug-28	Alector to Participate in Upcoming Healthcare Conferences ALEC GlobeNewswire
Aug-07	Alector Reports Second Quarter 2025 Financial Results and Provides Business Update ALEC GlobeNewswire
Jul-31	Alector to Host Second Quarter and Mid-Year 2025 Earnings Conference Call ALEC GlobeNewswire
Jun-13	Alector Provides Executive Leadership Update ALEC GlobeNewswire
Jun-03	Alector to Participate in the Goldman Sachs 46th Annual Global Healthcare Conference ALEC GlobeNewswire
May-08	Alector Reports First Quarter 2025 Financial Results and Provides Business Update ALEC GlobeNewswire
May-06	Alector to Participate in Upcoming Healthcare Conferences ALEC GlobeNewswire